Literature DB >> 10523006

Hormonal and biochemical parameters in the determination of osteoporosis in elderly men.

J R Center1, T V Nguyen, P N Sambrook, J A Eisman.   

Abstract

The extent to which changes in several hormonal and biochemical parameters are involved in the pathogenesis of osteoporosis in men remains controversial. This study examined the roles of free testosterone (T), estradiol (E2), sex hormone-binding globulin (SHBG), 25-hydroxyvitamin D, PTH, and insulin-like growth factor I in the determination of bone mineral density (BMD) in 437 community-dwelling elderly men. Age, height, weight, quadriceps strength, and femoral neck (FN) and lumbar spine (LS) BMD were also obtained. In multiple regression analysis, after adjusting for age and weight, low E2 (P = 0.01), and high SHBG (P = 0.0002) levels were common determinants of FN and LS BMD. In addition, high PTH (P = 0.03) was an independent predictor of FN BMD, and low free T (P = 0.02) was an independent predictor of LS BMD. Low free T was associated with FN BMD in univariate analysis only. The hormonal measurements collectively accounted for 5% and 7% of the age- and weight-adjusted variance of FN and LS BMD, respectively. The sex steroids, SHBG and insulin-like growth-I were found to be interrelated using a technique of path analysis that examines the intercorrelation between these variables. A subject with any one abnormal serum parameter had a 4-fold increase in the risk of osteoporosis, whereas three abnormal parameters were associated with an 11-fold increased risk, although the latter group only applied to 1% of the study population. Although the precise causal effects these biochemical parameters may have on the development of osteoporosis remains to be determined, the present findings support an important interrelated role for these hormonal and biochemical parameters on changes in bone density in elderly men.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523006     DOI: 10.1210/jcem.84.10.6051

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  53 in total

Review 1.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Osteoporosis in men.

Authors:  G M Prelevic
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

3.  Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.

Authors:  A Gürlek; O Gedik
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

Review 4.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

5.  The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study.

Authors:  Elizabeth Barrett-Connor; Gail A Laughlin; Hong Li; Carrie M Nielson; P Ying Wang; Tien T Dam; Jane A Cauley; Kristine E Ensrud; Marcia L Stefanick; Edith Lau; Andrew R Hoffman; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

Review 6.  Genetic profiling and individualized assessment of fracture risk.

Authors:  Tuan V Nguyen; John A Eisman
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

Review 7.  The pathogenesis, treatment and prevention of osteoporosis in men.

Authors:  Leif Mosekilde; Peter Vestergaard; Lars Rejnmark
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 8.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

9.  Gonadal sex steroid status and bone health in middle-aged and elderly European men.

Authors:  D Vanderschueren; S R Pye; K Venken; H Borghs; J Gaytant; I T Huhtaniemi; J E Adams; K A Ward; G Bartfai; F F Casanueva; J D Finn; G Forti; A Giwercman; T S Han; K Kula; F Labrie; M E J Lean; N Pendleton; M Punab; A J Silman; F C W Wu; T W O'Neill; S Boonen
Journal:  Osteoporos Int       Date:  2009-12-15       Impact factor: 4.507

10.  Estrogen and bone: insights from estrogen-resistant, aromatase-deficient, and normal men.

Authors:  Sundeep Khosla
Journal:  Bone       Date:  2008-05-16       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.